Evidence map›Paper›PMID 31462916›Full record

ArticleEvolutionary applications2019

Natural

Diego Ayala, Ousman Akone-Ella, Nil Rahola, Pierre Kengne, Marc F Ngangue, Fabrice Mezeme, Boris K Makanga, Martha Nigg, Carlo Costantini, Frédéric Simard and 4 more

Abstract read
In one paragraph

Article in Evolutionary applications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Updates on traditional methods for combating malaria and emergingFrontiers in cellular and infection microbiology · 2024
    Review
  13. Article
  14. Genetic diversity of endosymbiotic bacteriaFrontiers in microbiology · 2024
    Article
  15. Limited association betweenEvolutionary applications · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Microbial genomics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Diego AyalaMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.ORCID https://orcid.org/0000-0003-4726-580X
Ousman Akone-EllaCIRMF Franceville Gabon.
Nil RaholaMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Pierre KengneMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Marc F NgangueCIRMF Franceville Gabon.
Fabrice MezemeCIRMF Franceville Gabon.
Boris K MakangaCIRMF Franceville Gabon.
Martha NiggMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Carlo CostantiniMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Frédéric SimardMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Franck PrugnolleMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Benjamin RocheMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Olivier DuronMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.
Christophe PaupyMIVEGEC, IRD, CNRS Université de Montpellier Montpellier France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last decade, the endosymbiont bacterium

Indexed as

Anophelesco‐evolutiondisease controldiversityWolbachia

Identifiers

PMID31462916
PMCPMC6708434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.